Trading at the beginning of the week
US stock indices are showing a slight decline at the start of trading on Monday after a strong rise on Friday and all of last week's results.
The Dow Jones Industrial Average index was down 5.52 points (0.02%) a...
Vaccine for children
Pfizer and BioNTech have urged US authorities to approve a coronavirus vaccine for children aged 6 months to 5 years, according to a statement published on Pfizer's website on Tuesday.
Pfizer's Albert Bourla said...
Stock indices on Tuesday
US stock indices will open lower, which could be another volatile session for investors after Monday's strong swings. Nasdaq Composite futures are down 2%, while S&P 500 and Dow Jones futures are down about 0.7%.
On Tue...
'Person of the Year' title
The head of the US company Tesla, Elon Musk, was named person of the year by the British Financial Times on Wednesday, thanks to his efforts to bring about "a historic automotive&nbs...
Omicron not a threat to the economy
US stock futures are set for a third day of gains as investors bet that the new variant of the COVID-19 virus will not pose a major threat to the economy.
Major futures indices are anticipating a 0.3% rise at the...
New strain and the economy
US stock indices fell before the opening of trading on Tuesday after Fed Chairman Jerome Powell said risks to the economy, the labour market and inflation could become more difficult with...
Fighting a new strain
The stock market recovered slightly at the premarket on Monday after a sharp fall on Friday when the World Health Organisation (WHO) said that the new COVID-19 strain first identified in South Africa was a "strain of concern".
...
Booster vaccines
The FDA and CDC in the US on Friday approved Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA) booster vaccines against COVID-19 for all adults in the US. Revaccination with J&...
Government contract for Pfizer
Shares in Pfizer (PFE) have risen amid reports that the US government has ordered 10 million courses of treatment with its Pfizer Paxlovid tablets for COVID-19.
President Joe Biden said o...
Weekly Schedule
U.S. inflation data for October and quarterly earnings reports from Coinbase (COIN), PayPal (PYPL), Palantir (PLTR) and Disney (DIS), as well as the Rivian IPO will be the focus of stock market participants this week.
Stocks this we...
2021 outlook
Pfizer (PFE) shares rose sharply by 4% on Tuesday after the company beat analysts' Q3 revenue and earnings estimates and raised its sales forecast for 2021. Pfizer investors are encouraged by expected sales of booster doses of COVID-19 ...
Booster vaccines
CVS and Walgreens pharmacies across the country are administering Pfizer's COVID-19 vaccine boosters to millions of eligible Americans who are most at risk of contracting the virus.
About 6,000 CVS pharmacies and MinuteClinic acros...
2-in-1 vaccine
Moderna's shares have increased dramatically after the announcement of the development of a comprehensive booster vaccine that simultaneously protects against new strains of the COVID-19 virus and seasona...
Share price rises
Moderna shares hit a new high on Monday, ending trading up 17% on news of Australia ordering 25 million Moderna vaccines from COVID-19 and recent research showing greater efficacy from the Delta strain of Moderna vaccine than Pfize...
COVID-19 vaccine
The US administration has purchased a further 200 million doses of coronavirus vaccine from a US company and its German partner BioNTech. This was confirmed by White House press secretary Jennifer ...
Vaccine effectiveness
BioNTech (NASDAQ:BNTX) and Pfizer (NYSE:PFE) shares weakened in Tuesday's premarket as a study in Israel found that in recent weeks their vaccine began to lose effectiveness in preventing the COVID-19 delta strain and the&...
Vaccine approval application
Novavax will be another major international supplier of vaccines against COVID-19, as trials of its NVX-CoV2373 vaccine have shown an overall effectiveness of 90.4% with good tolerability. Novavax expects coronaviru...
Shares plummet
Moderna (NASDAQ:MRNA) shares tumbled more than 10% at the opening of trading in New York on Thursday on the back of the Biden administration's decision to support a COVID-19 vaccine intellectual...
FDA approves vaccine
Johnson&Johnson has received approval for emergency use of its vaccine in the US, with the advantages of single-dose administration and standard storage requirements.
Johnson&Johnson receiv...
Vaccine trial and delivery
Johnson & Johnson is preparing to present the results of the final trials of its COVID-19 vaccine in the next week or two, according to Anthony Fauci, chief medical officer for infectious ...
- 1
- 2
NEW YORK NEWS
News from GlobalNY.biz is the freshest and most relevant information about high-profile events in the region. The task of the resource's news feed is to convey to readers with maximum accuracy and objectivity information about important events in business, politics, economy, healthcare, culture and other spheres of life in New York.
GlobalNY.biz news is a coverage of economic processes taking place in New York, the latest news of public life, incidents and an overview of political events. New York news is information about the activities of small and medium-sized businesses, the work of housing and communal services and utilities, the implementation of significant projects.
The site's journalists describe not only the life of the region, but also talk about the current state of the US economy. Everything you need to know about innovations in the field of industry and agriculture, economy and power is collected in the "News" section at GlobalNY.biz.
New York news quickly informs the reader, shows the real picture and opens up hot topics. Communication with government structures and business enables us to provide our readers with reliable, information-rich material. The main page of the portal contains the key news of New York!
Alena Potapova
Development Director
